122 related articles for article (PubMed ID: 15068633)
1. A poorly differentiated thyroid carcinoma with neuroendocrine traits.
Boronat M; Isla C; Nóvoa FJ; Cabrera JJ
Thyroid; 2004 Feb; 14(2):163-4. PubMed ID: 15068633
[No Abstract] [Full Text] [Related]
2. Neuroendocrine differentiation in non-neuroendocrine thyroid carcinoma.
Kargi A; Yörükoglu ; Aktaş S; Cakalagaoglu ; Ermete M
Thyroid; 1996 Jun; 6(3):207-10. PubMed ID: 8837328
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity.
Chernyavsky VS; Farghani S; Davidov T; Ma L; Barnard N; Amorosa LF; Trooskin SZ
Thyroid; 2011 Feb; 21(2):193-6. PubMed ID: 21275766
[TBL] [Abstract][Full Text] [Related]
4. C cell carcinoma of the thyroid. Follicular variant.
Lertprasertsuke N; Kakudo K; Nakamura A; Tada N; Osamura Y; Watanabe K; Kubota M
Acta Pathol Jpn; 1989 Jun; 39(6):393-9. PubMed ID: 2481937
[TBL] [Abstract][Full Text] [Related]
5. Metastasizing neuroendocrine carcinoma of the larynx with calcitonin and somatostatin secretion and CEA production, resembling medullary thyroid carcinoma.
Smets G; Warson F; Dehou MF; Storme G; Sacré R; Van Belle S; Somers G; Gepts W; Klöppel G
Virchows Arch A Pathol Anat Histopathol; 1990; 416(6):539-43. PubMed ID: 1970917
[TBL] [Abstract][Full Text] [Related]
6. Medullary carcinoma of the thyroid gland: an immunocytochemical study.
Holm R; Sobrinho-Simões M; Nesland JM; Gould VE; Johannessen JV
Ultrastruct Pathol; 1985; 8(1):25-41. PubMed ID: 3901454
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin gene-related peptide (CGRP) - microadenomas of the thyroid gland induced by cadmium toxicity. Experimental study.
Jancic S; Bojanic V; Rancic G; Joksimovic I; Jancic N; Zindovic M; Stankovic V
J BUON; 2011; 16(2):331-6. PubMed ID: 21766506
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine differentiation in follicle-cell thyroid carcinoma: correlation to prognostic factors in papillary carcinoma.
Tseleni-Balafouta S; Kavantzas N; Alevizaki M; Paraskevakou H; Davaris P
J Exp Clin Cancer Res; 1998 Dec; 17(4):533-7. PubMed ID: 10089080
[TBL] [Abstract][Full Text] [Related]
9. Chromogranin A and the alpha-subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma.
Guignat L; Bidart JM; Nocera M; Comoy E; Schlumberger M; Baudin E
Br J Cancer; 2001 Mar; 84(6):808-12. PubMed ID: 11259096
[TBL] [Abstract][Full Text] [Related]
10. Many faces of mixed medullary-follicular and papillary carcinoma of the thyroid.
Monden T; Mori M
Intern Med; 1998 Nov; 37(11):909-10. PubMed ID: 9868948
[No Abstract] [Full Text] [Related]
11. Thyroid carcinoma with biphasic clinical course and evolution in medullary carcinoma-follicular variant. A case report and an immunocytochemical demonstration of calcitonin and thyroglobulin in the same neoplastic cells.
Baschieri I; Ronga G; Fiorentino A; Mariani P; Carlei F
J Nucl Med Allied Sci; 1990; 34(2):71-6. PubMed ID: 2246675
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical characterization of neuroendocrine tumours of the larynx.
Salim SA; Milroy C; Rode J; Corrin B; Hamid Q
Histopathology; 1993 Jul; 23(1):69-73. PubMed ID: 7690008
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine marker expression in thyroid epithelial tumors.
Satoh F; Umemura S; Yasuda M; Osamura RY
Endocr Pathol; 2001; 12(3):291-9. PubMed ID: 11740050
[TBL] [Abstract][Full Text] [Related]
14. [Concurrent medullary and papillary thyroid carcinoma: report of a case].
Lin KR; Huang ZL; Huang XW; Zheng XY; Chen GR
Zhonghua Bing Li Xue Za Zhi; 2012 Apr; 41(4):279-80. PubMed ID: 22800531
[No Abstract] [Full Text] [Related]
15. Hyalinizing trabecular adenoma of the thyroid. A report of three cases with immunohistochemical and ultrastructural studies.
Katoh R; Jasani B; Williams ED
Histopathology; 1989 Sep; 15(3):211-24. PubMed ID: 2478437
[TBL] [Abstract][Full Text] [Related]
16. Adenocarcinoma of the colon with neuroendocrine features and secretory diarrhea.
Lew EA; Lewin KJ; Zarchy T; Pisegna JR
Am J Gastroenterol; 1999 Jun; 94(6):1692-4. PubMed ID: 10364049
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
[TBL] [Abstract][Full Text] [Related]
18. Chromogranin A: an additional tumor marker for postoperative recurrence and metastases of medullary thyroid carcinomas?
Franke WG; Pinkert J; Runge R; Bredow J; Wunderlich G; Koch R
Anticancer Res; 2000; 20(6D):5257-60. PubMed ID: 11326706
[TBL] [Abstract][Full Text] [Related]
19. In vivo somatostatin receptor imaging in medullary thyroid carcinoma.
Kwekkeboom DJ; Reubi JC; Lamberts SW; Bruining HA; Mulder AH; Oei HY; Krenning EP
J Clin Endocrinol Metab; 1993 Jun; 76(6):1413-7. PubMed ID: 8501144
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy.
Valli N; Catargi B; Ronci N; Leccia F; Guyot M; Roger P; Ducassou D; Tabarin A
Thyroid; 1999 Jun; 9(6):583-9. PubMed ID: 10411121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
